Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
181,259,081
-
Total 13F shares
-
10,028
-
Share change
-
+10,028
-
Total reported value
-
$33,293
-
Price per share
-
$3.32
-
Number of holders
-
1
-
Value change
-
+$33,293
-
Number of buys
-
1
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q4 2023
As of 31 Dec 2023,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
10,028 shares.
The largest 10 holders included
FMR LLC, Casdin Capital, LLC, BlackRock Inc., Avidity Partners Management LP, DAFNA Capital Management LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, FEDERATED HERMES, INC., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.